Volume 49, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Genotypic heterogeneity in the repetitive portion of the circumsporozoite (CS) protein of has been reported from many -endemic areas. The objective of this study was to determine if the VK210 and VK247 CS variants of differed in their clearance rates following chloroquine (CQ) therapy. One hundred seventy-one cases of infection occurring in patients presenting to a research treatment center in Thailand were analyzed. Finger-prick blood samples were collected for microscopy and spotted onto filter paper at presentation and on each of five days of observation through supervised CQ therapy. A portion of the CS gene was amplified from filter paper samples by the polymerase chain reaction (PCR) and genotyped by oligoprobes specific for the VK210 and VK247 CS repeat regions. The mean time to clear parasitemia as determined by thick blood smear was significantly longer for pure VK210 infections (51 hr; 95% confidence interval [CI] 47.4–54, = 0.006) and mixed infections (53 hr; 95% CI 49.2–56.7, = 0.0009) as compared with VK247 infections (44 hr; 95% CI 39.8–47.9). Five patients matched for parasitemia, age, sex, and previous malaria experience were selected from each of the three genotype groups in the larger study for further analysis by quantitative PCR of genotype-specific DNA during a treatment course. The mean time to clear parasite DNA, as determined by PCR, was significantly slower for VK210 parasites (65 hr; 95% CI 51–79) than for VK247 parasites (47 hr; 95% CI 30–63, = 0.045). In patients with mixed infections, VK210 DNA also cleared more slowly (mean 66 hr; 95% CI 40–93) than VK247 DNA (mean 35 hr; 95% CI 23–47, = 0.056). These results suggest that strain-variable responses to CQ may exist. Detection and quantification of genotype-specific DNA from filter paper samples may be useful as a method to monitor response to chemotherapy in a field setting.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...


Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error